VA Loma Linda Health Care System
10
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
20.0%
2 terminated/withdrawn out of 10 trials
71.4%
-15.1% vs industry average
20%
2 trials in Phase 3/4
40%
2 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD
Role: lead
Warfarin Patient Self-management Implementation in the US Healthcare System
Role: collaborator
Effect of Statin Therapy on C-reactive Protein Levels in Patients With Chronic Obstructive Lung Disease (COPD)
Role: lead
Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude
Role: lead
Non-invasive Pulmonary Artery Prediction (ADOPTS)
Role: collaborator
Role of the Auditory Efferent System in Auditory Perceptual Learning
Role: lead
Minimally-Invasive Cardiovascular Hemodynamic Optimization (MiCHO) Versus Early Goal-Directed Therapy (EGDT) in the Management of Septic Shock
Role: collaborator
In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis
Role: collaborator
Effects of Iloprost on Hypoxic Pulmonary Vasoconstriction and Exercise Capacity at High Altitude
Role: lead
Effect of Bosentan on Exercise Capacity at High Altitude
Role: lead
All 10 trials loaded